shilav- ג'ל היגייני לידיים
א.ל. ארמן יצור תמרוקים בעמ - הגיינת הידיים
shilav - קרם הזנה לבטן לאחר לידה
א.ל. ארמן יצור תמרוקים בעמ - הזנה לעור
shilav - קרם הזנה בתקופת ההריון
א.ל. ארמן יצור תמרוקים בעמ - הזנה לעור
מרקפטיזול
taro pharmaceutical industries ltd - methimazole - טבליה - methimazole 20 mg - thiamazole - thiamazole - for the treatment of hyperthyroidism.
reogo
motorika medical(isra - רופא - מערכת רובוטית לשיקום מוטורי של הגפיים העליונות
hand held biometer+pachimeter palm
אבנט ציוד רפואי בע"מ - רופא - מכשיר לבדיקת הקרנית ) עובי + צורה (
מונטק 10-40 gbq גנרטור רדיונאוקלאוטידים
hila pharma, israel - sodium (99mtc) pertechnetate; sodium molybdate - גנרטור לדימות - sodium (99mtc) pertechnetate 8.3 - 33.9 gbq; sodium molybdate 10 - 40 gbq
גליבק 100 מג
novartis israel ltd - imatinib as mesylate - טבליות מצופות פילם - imatinib as mesylate 100 mg - imatinib - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic l
גליבק 400 מג
novartis israel ltd - imatinib as mesylate - טבליות מצופות פילם - imatinib as mesylate 400 mg - imatinib - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic l